Efficacy and Tolerability of ZD6474 in Patients With Thyroid Cancer



Status:Completed
Conditions:Cancer, Cancer, Endocrine, Thyroid Cancer
Therapuetic Areas:Endocrinology, Oncology
Healthy:No
Age Range:18 - 127
Updated:5/9/2018
Start Date:November 2004
End Date:April 19, 2017

Use our guide to learn which trials are right for you!

An Open Label, Two Stage, Phase II Study to Evaluate the Efficacy and Tolerability of ZD6474 in Patients With Locally Advanced or Metastatic Hereditary Medullary Thyroid Carcinoma.

The purpose of this open label, two stage, phase II study is to evaluate the efficacy and
tolerability of ZD6474 in patients with locally advanced or metastatic hereditary medullary
thyroid carcinoma.


Inclusion Criteria:

- Locally advanced or hereditary medullary thyroid cancer

- Signed informed consent

- One or more measurable lesions

Exclusion Criteria:

- Brain metastases or spinal cord compression

- Specific laboratory ranges

- Specific heart problems

- Prior chemotherapy and/or radiation therapy

- Participation in other trials within 30 days
We found this trial at
6
sites
?
mi
from
New York, NY
Click here to add this to my saved trials
?
mi
from
Durham, NC
Click here to add this to my saved trials
?
mi
from
Houston, TX
Click here to add this to my saved trials
?
mi
from
New Haven, CT
Click here to add this to my saved trials
?
mi
from
San Francisco, CA
Click here to add this to my saved trials
?
mi
from
Villejuif Cedex,
Click here to add this to my saved trials